Both in Pharmaceuticals
Arrowhead Research vs Corcept Therapeutics
Over the past year ARWR returned +50.4% and CORT returned +8.5%; their daily moves had a correlation of 0.15.
ARWR +50.4% CORT +8.5%Growth of $1, one year, split-adjusted
| Metric | ARWR | CORT |
|---|---|---|
| Price | $59.57 | $80.46 |
| Market cap | $8.41B | $8.70B |
| Today | −0.55% | −0.81% |
| 1 month | −7.2% | −30.8% |
| 6 months | −22.0% | +55.9% |
| Year to date | −10.3% | +131.2% |
| 1 year | +40.8% | +11.3% |
| Revenue growth (YoY) | +171.0% | +31.7% |
| Gross margin | 100.0% | 98.4% |
| Net margin | −258.2% | 16.8% |
| P/E (TTM) | — | 159.6× |
| Price / sales | 12.6× | 10.5× |
| Net cash | $737.9M | $308.2M |
| Dividend yield | — | — |
| Volatility (60d) | 45.2% | 59.6% |
| Short % of float | 8.1% | 9.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).